4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-25-027074
Options or other derivatives
- Chief Commercial Officer acquired 23,296 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Maizel Ari Chief Commercial Officer | 2025-02-21 | Grant or award · Employee Stock Option (Right to Buy) | +7,816 | 7,816 | D | ||
| Maizel Ari Chief Commercial Officer | 2025-02-21 | Grant or award · Restricted Stock Units | +7,740 | 7,740 | D | ||
| Maizel Ari Chief Commercial Officer | 2025-02-24 | Grant or award · Performance Stock Units | +7,740 | 7,740 | D | ||
Loading xslF345X05/ownership.xml…